• Adverse events associated with nevirapine use in pregnancy: a systematic review and meta-analysis

      Ford, N; Calmy, A; Andrieux-Meyer, I; Hargreaves, S; Mills, E J; Shubber, Z; Médecins Sans Frontières, Geneva, Switzerland. nathan.ford@msf.org (Lippincott Williams & Wilkins, 2013-04-24)
      The risk of adverse drug events associated with nevirapine (NVP) is suggested to be greater in pregnant women. We conducted a systematic review and meta-analysis of severe adverse events in HIV-positive women who initiated NVP while pregnant.